These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26998095)

  • 1. AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway.
    Wu J; Yang L; Shan Y; Cai C; Wang S; Zhang H
    Oncol Lett; 2016 Mar; 11(3):1889-1894. PubMed ID: 26998095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
    Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
    Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.
    Hehlgans S; Lange I; Eke I; Cordes N
    Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase A induces chemotherapy resistance through revival of dormant cells in laryngeal squamous cell carcinoma.
    Yang LY; Shan YM; Zhang Y; Zhou EH; Chen XP; Zhang H
    Head Neck; 2019 Jul; 41(7):2239-2248. PubMed ID: 30706572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.
    Lee JW; Parameswaran J; Sandoval-Schaefer T; Eoh KJ; Yang DH; Zhu F; Mehra R; Sharma R; Gaffney SG; Perry EB; Townsend JP; Serebriiskii IG; Golemis EA; Issaeva N; Yarbrough WG; Koo JS; Burtness B
    Clin Cancer Res; 2019 Jun; 25(11):3430-3442. PubMed ID: 30755439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma.
    Baumann A; Buchberger AMS; Piontek G; Schüttler D; Rudelius M; Reiter R; Gebel L; Piendl G; Brockhoff G; Pickhard A
    Oncotarget; 2018 Feb; 9(16):12769-12780. PubMed ID: 29560108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
    Kurio N; Shimo T; Fukazawa T; Okui T; Hassan NM; Honami T; Horikiri Y; Hatakeyama S; Takaoka M; Naomoto Y; Sasaki A
    Oral Oncol; 2012 Nov; 48(11):1159-70. PubMed ID: 22766511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
    Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
    Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling.
    Kim SA; Kwon SM; Kim JA; Kang KW; Yoon JH; Ahn SG
    Cancer Lett; 2011 Jul; 306(2):197-204. PubMed ID: 21463917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells.
    Yang Y; Wang Y; Che X; Hou K; Wu J; Zheng C; Cheng Y; Liu Y; Hu X; Zhang J
    Oncol Lett; 2021 Jul; 22(1):556. PubMed ID: 34084223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect.
    Zhang Y; Sun X
    Onco Targets Ther; 2020; 13():10207-10220. PubMed ID: 33116602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
    Hehlgans S; Eke I; Cordes N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling.
    Zhong D; Ran JH; Tang WY; Zhang XD; Tan Y; Chen GJ; Li XS; Yan Y
    Asian Pac J Cancer Prev; 2012; 13(6):2897-901. PubMed ID: 22938480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
    Yousif NG
    Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.